Intellectus Partners, LLC Iovance Biotherapeutics, Inc. Transaction History

Intellectus Partners, LLC

$394 Million
Q1 2025

A detailed history of Intellectus Partners, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Intellectus Partners, LLC holds 116,212 shares of IOVA stock, worth $413,714. This represents 0.1% of its overall portfolio holdings.

Number of Shares

116,212

Previous 114,912 1.13%

Holding current value

$413,714

Previous $850,000 51.41%

% of portfolio

0.1%

Previous 0.19%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 11, 2025	BUY	$3.44 - $7.79 $4,472 - $10,127	1,300 Added 1.13%	116,212 $413,000
Q4 2024 Feb 07, 2025	BUY	$7.17 - $12.28 $11,350 - $19,439	1,583 Added 1.4%	114,912 $850,000
Q3 2024 Nov 06, 2024	SELL	$7.28 - $11.9 $4,368 - $7,140	-600 Reduced 0.53%	113,329 $1.06 Million
Q2 2024 Jul 18, 2024	SELL	$7.78 - $14.19 $31,120 - $56,760	-4,000 Reduced 3.39%	113,929 $913,000
Q1 2024 May 03, 2024	BUY	$7.59 - $17.47 $9,487 - $21,837	1,250 Added 1.07%	117,929 $1.75 Million
Q4 2023 Feb 05, 2024	SELL	$3.3 - $8.89 $11,880 - $32,004	-3,600 Reduced 2.99%	116,679 $948,000
Q3 2023 Oct 25, 2023	BUY	$4.44 - $8.79 $1,110 - $2,197	250 Added 0.21%	120,279 $547,000
Q2 2023 Jul 31, 2023	BUY	$5.36 - $9.06 $59,764 - $101,019	11,150 Added 10.24%	120,029 $845,000
Q1 2023 May 04, 2023	BUY	$5.53 - $8.22 $117,396 - $174,502	21,229 Added 24.22%	108,879 $665,000
Q4 2022 Feb 02, 2023	BUY	$5.62 - $10.0 $234,202 - $416,730	41,673 Added 90.64%	87,650 $560,000
Q2 2022 Aug 12, 2022	BUY	$6.38 - $18.33 $53,445 - $153,550	8,377 Added 22.28%	45,977 $508,000
Q1 2022 May 16, 2022	SELL	$12.38 - $19.1 $30,950 - $47,750	-2,500 Reduced 6.23%	37,600 $626,000
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $309,485 - $516,681	-18,700 Reduced 31.8%	40,100 $765,000
Q3 2021 Nov 16, 2021	BUY	$20.35 - $26.63 $15,262 - $19,972	750 Added 1.29%	58,800 $1.45 Million
Q2 2021 Aug 13, 2021	BUY	$16.33 - $33.07 $253,114 - $512,585	15,500 Added 36.43%	58,050 $1.51 Million
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $27,236 - $49,960	950 Added 2.28%	42,550 $1.35 Million
Q4 2020 Feb 18, 2021	BUY	$28.04 - $50.26 $1.14 Million - $2.05 Million	40,728 Added 4670.64%	41,600 $1.93 Million
Q4 2020 Feb 12, 2021	SELL	$28.04 - $50.26 $949,939 - $1.7 Million	-33,878 Reduced 97.49%	872 $1.93 Million
Q3 2020 Nov 16, 2020	BUY	$27.75 - $36.3 $139,166 - $182,044	5,015 Added 16.87%	34,750 $1.14 Million
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $487,059 - $733,900	17,900 Added 151.25%	29,735 $816,000
Q1 2020 May 14, 2020	BUY	$19.54 - $38.85 $60,574 - $120,435	3,100 Added 35.49%	11,835 $354,000
Q4 2019 Jan 24, 2020	BUY	$17.95 - $29.41 $156,793 - $256,896	8,735 New	8,735 $242,000

Others Institutions Holding IOVA

# of Institutions

343

Shares Held

247M

Call Options Held

2.51M

Put Options Held

3.5M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $562M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intellectus Partners, LLC with notifications on news.

Account

Intellectus Partners, LLC Iovance Biotherapeutics, Inc. Transaction History